tirzepatide and dementia the Brain: A Breakthrough in Combating Diabetes-Linked Neurodegeneration Tirzepatide Effects on Brain: Neuroprotection

The median incubation period for COVID-19 was estimated to be 5.1 days, and 99% (101 out of every 10,000 cases) will develop symptoms after 14 days 107,108

Given the widespread use of these medications for metabolic diseases, clinicians and researchers are now examining how they impact the brain particularly regarding mood, depression, and addictive behaviors

This determines how much liquid you draw per dose

This is especially important for people with diabetes who also have heart issues, kidney problems, or are overweight

Phase 2a trial of GSBR-1290 (45mg and 90mg) in 54 T2DM patients over 12 weeks observed significant reduction in HbA1c (45 mg: -1.01%, p=0.008